Overview

In Perth, The Early Disease Surveillance program began in 1996 under the direction of Dr. Siobhain Brennan and Professor Peter Sly to initially investigate the role in inflammation in the lungs of children with cystic fibrosis. Royal Children's Hopsital in Melbourne has a long history of research into early lung function and pulmonary inflammation in cystic fibrosis. From a small beginning in Perth, the current program has grown into a comprehensive assessment of early disease in cystic fibrosis, expanding to include Melbourne's Royal Children's Hospital in 2005. This program has developed to become internationally recognised and is at the forefront of research in the detection, prevention and treatment of early lung disease in cystic fibrosis.